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White coat color has been a highly valued trait in horses for at least 2,000 years. Dominant white (W) is one of several
known depigmentation phenotypes in horses. It shows considerable phenotypic variation, ranging from ;50%
depigmented areas up to a completely white coat. In the horse, the four depigmentation phenotypes roan, sabino,
tobiano, and dominant white were independently mapped to a chromosomal region on ECA 3 harboring the KIT gene.
KIT plays an important role in melanoblast survival during embryonic development. We determined the sequence and
genomic organization of the ;82 kb equine KIT gene. A mutation analysis of all 21 KIT exons in white Franches-
Montagnes Horses revealed a nonsense mutation in exon 15 (c.2151C.G, p.Y717X). We analyzed the KIT exons in
horses characterized as dominant white from other populations and found three additional candidate causative
mutations. Three almost completely white Arabians carried a different nonsense mutation in exon 4 (c.706A.T,
p.K236X). Six Camarillo White Horses had a missense mutation in exon 12 (c.1805C.T, p.A602V), and five white
Thoroughbreds had yet another missense mutation in exon 13 (c.1960G.A, p.G654R). Our results indicate that the
dominant white color in Franches-Montagnes Horses is caused by a nonsense mutation in the KIT gene and that
multiple independent mutations within this gene appear to be responsible for dominant white in several other modern
horse populations.
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Introduction
Dominant white (W) is an autosomal dominant trait that is
characterized by coat depigmentation of variable extent.
Caused by the absence of melanocytes from the depigmented
skin areas, expressivity can range from ;50% depigmented
areas up to a nearly completely white coat. In contrast to
horses with grey coat color (G), which are characterized by
progressive greying of the hair, white horses show the
depigmentation at birth and have a depigmented skin. Eyes
are normally pigmented in dominant white horses, probably
due to the different origin of the retinal melanocytes, which
develop from local neuroectoderm and not from the neural
crest, as do the skin melanocytes. In various horse breeds,
cases of white or almost white horses born out of solid-
colored parents have been reported [1]. Some breed registries
have restrictions towards this phenotype, or do not allow the
phenotype to be registered. In the Franches-Montagnes
Horse population white horses are known and reported to
trace back to the white founder mare Cigale, born in 1957 [2].
The Camarillo White Horses, which have a similar depig-
mentation phenotype, represent another famous line of
horses that can be traced back to the white founder stallion
Sultan, born in 1912 [3]. According to anecdotal reports from
breeders, the dominant white phenotype appears to have
originated independently on several occasions in Thorough-
breds. The white coat color phenotype is inherited as a
monogenic autosomal dominant trait. In one study, white
horses were shown to be obligate heterozygous (W/þ), as the
W/W genotype was hypothesized to cause early embryonal
lethality [4].
In horses, the four depigmentation phenotypes roan,
sabino-1, tobiano, and dominant white were independently
mapped to a region on equine Chromosome 3 (ECA 3)
harboring the KIT gene [2,5–7]. The sabino-1 spotting pattern
is caused by an intronic mutation in the KIT gene, which
causes partial skipping of exon 17 [6]. The tobiano spotting
pattern is caused by a large chromosomal inversion that
disrupts a potential regulatory element downstream of the
KIT gene [7]. In contrast to sabino and tobiano, the mutations
for roan and dominant white have been reported to cause
lethality in the homozygous state in some horse breeds [4,8].
KIT is a type III receptor protein-tyrosine kinase and
belongs to a protein subfamily including the colony stimulat-
ing factor-1 receptor (CSF1R), platelet-derived growth factor
receptor (PDGFR), and fms-related tyrosine kinase 3 (FLT3).
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KIT contains an extracellular domain composed of ﬁve
immunoglobulin domains, a single transmembrane domain,
a juxtamembrane domain, and an intracellular protein kinase
domain that is interrupted by an insertion of about 80 amino
acids [9]. The KIT ligand (KITL), also called stem cell factor
(SCF), binds to KIT via the second and third extracellular
immunoglobulin domains. Ligand binding induces receptor
dimerization, thereby activating the intrinsic tyrosine kinase
domain through transphosphorylation and further signal
transduction [10]. KIT has the potential to participate in
multiple signaling pathways, which accounts for its important
role in the control of cell differentiation, proliferation,
survival, and motility. A complete loss of function of KIT
causes prenatal or perinatal lethality due to anemia [11]. KIT
signaling is crucial for the development and survival of
melanoblasts, mast cells, spermatogonia, and the interstitial
cells of Cajal in the gastrointestinal tract [12]. Receptor-
inactivating point mutations in the KIT gene often act
dominantly or semidominantly and are associated with
hypopigmentation, anemia, and/or sterility. The dominant
or semidominant inheritance is either due to haploinsufﬁ-
ciency or to the fact that mutated KIT receptors may form
heterodimers with wild-type KIT receptors and thus act fully
or partially dominant negative. Inactivating KIT mutations
cause piebaldism in humans and white or spotted W mutants
in mice [13–17]. Gain-of-function mutations in the proto-
oncogene KIT are involved in the formation of gastro-
intestinal stromal tumors, myelogenous leukemia, and mas-
tocytomas [18].
Here, we report the complete genomic organization of the
equine KIT gene and an analysis of the KIT gene sequence in
horses with depigmentation phenotypes.
Results
Genomic Sequence of the Equine KIT Gene
We identiﬁed and sequenced an equine BAC clone
harboring the entire KIT gene. This sequence corresponds
to positions 6,812,854–7,023,775 on scaffold 10 of the ﬁrst
horse genome assembly, which was published during the
progress of our work. The genomic organization of the
equine KIT gene was inferred by comparison of the genomic
sequence with the cDNA sequence from public databases. The
equine KIT gene spans a genomic region of about 82 kb and
comprises 21 exons, similar to the human KIT gene. The
equine KIT mRNA contains an open reading frame of 2,919
bp encoding a protein of 972 amino acids. The encoded
peptide is predicted to have a molecular weight of 108.9 kDa,
a pI of 6.3, and 88% identity to the human and 82% identity
to the orthologous mouse protein, respectively.
Mutation Analysis in Franches-Montagnes Horses
We selected four white and four solid-colored Franches-
Montagnes horses from a three-generation family for the
initial mutation analysis (see Figure 1 for an overview on
phenotypes and Figure S1 for pedigree of the family).
Comparative sequencing of all 21 exons and adjacent
sequences revealed 15 SNPs in these closely related animals
(Table 1). Only one of the 15 polymorphisms showed perfect
cosegregation of the genotypes with the dominant white
phenotype in the initial family. The cosegregating poly-
morphism was a C-to-G transversion located in exon 15
(c.2151C.G), which introduced a premature stop codon in
the open reading frame of the KIT protein (p.Y717X). The
mutation was predicted to truncate the KIT protein in the
middle of the kinase insert domain (Figure S2). We conﬁrmed
the presence of the c.2151C.G polymorphism in the white
horses by sequencing genomic PCR products containing exon
15 in both directions (Figure 2A) and performing BccI RFLP
analysis of these PCR products. Furthermore, the poly-
morphism was also conﬁrmed on the transcript level by
sequencing reverse transcriptase PCR (RT-PCR) products
(Figure 2E).
Confirmation of the Association on the Population Level
We genotyped all available Franches-Montagnes samples (n
¼ 132) in our laboratory for the c.2151C.G polymorphism.
All 20 white horses, descendants of Cigale, were heterozygous
for the c.2151C.G polymorphism (Figure S1). To exclude the
possibility that this variant also occurs in solid-colored
horses, a cohort of 112 solid-colored Franches-Montagnes
Horses were genotyped and all of them were homozygous for
the wildtype C allele at position c.2151 (Table S1).
Functional Analysis of the c.2151C.G Mutation
Transcripts containing premature termination codons are
often subject to nonsense-mediated decay (NMD) or non-
sense-mediated exon skipping (NME). NMD and NME are
thought to be quality-control mechanisms by which cells can
limit the expression of aberrant proteins. We performed RT-
PCR on leukocyte RNA from a white horse using primers
located in exon 13 and exon 16. Analysis of the RT-PCR
products on agarose gels exclusively yielded the complete
cDNA-fragments including exon 15. Therefore, the
c.2151C.G mutation does not seem to induce NME
(unpublished data).
Direct sequencing of the RT-PCR product from a hetero-
zygous white horse revealed that the mutant transcript is
present, albeit at a lower level compared to the wild-type
transcript. From the quantitative analysis of the signal
intensity ratios in the electropherograms between genomic
DNA and cDNA, we estimated that the amount of mutant
transcript is about 50% of the amount of wild-type transcript
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Author Summary
White horses have always been highly valued by their human
owners. Their important role in history is reflected by their
widespread use as heraldic animals (e.g., on the flags of the German
states of Lower Saxony and North Rhine-Westphalia). In the Swiss
Franches-Montagnes Horse population, a completely white mare
named Cigale was born out of solid brown parents in 1957. The
white phenotype is inherited as an autosomal dominant trait and all
living white Franches-Montagnes Horses are descendants of Cigale.
We sequenced the KIT gene in white and solid-colored Franches-
Montagnes Horses and found a mutation that inactivates the gene
product and thus leads to a lack of pigment-forming cells in the skin
of white horses. We then analyzed white horses from other
populations and found three additional independent candidate
causative mutations in white Thoroughbreds, Arabians, and
Camarillo White Horses. The research thus revealed independent
mutation events leading to white coat color in different horse
populations. Our findings will allow genetic testing and a more
precise classification of horses with white coat color.
in leukocytes (Figure 2C). The other 50% of mutant
transcripts are probably degraded by NMD.
We further performed a western blot on protein extracts
from skin samples of a dominant white and a solid-colored
horse to investigate whether the predicted truncated KIT
protein is expressed in skin. The western blot of the solid-
colored horse showed a strong band of the expected size
(;150 kDa) for the glycosylated full-length KIT protein. The
skin sample from the dominant white horse yielded a weak
band at ;150 kDa and another weak band at ;120 kDa. The
size of the ;120 kDa band corresponds to the predicted size
of the truncated KIT protein, as the p.Y717X mutation should
Figure 1. Dominant White Phenotype in Horses
(A) Franches-Montagnes mare with little residual pigmentation.
(B, C) Dominant white Franches-Montagnes stallion showing partial depigmentation as a colt and almost complete depigmentation at 4 years of age.
(D) Dominant white Thoroughbred stallion.
(E) Dominant white Arabian stallion.
(F) Camarillo White Horse.
(G) Immunohistochemistry using a polyclonal KIT antibody on a skin biopsy from a solid-colored horse. Blue staining indicates KIT expression
throughout the epidermis. Melanin produced by melanocytes is visible as brown granules.
(H) Immunohistochemistry on a skin biopsy of a white horse. Note the weak blue staining and the complete absence of melanocytes and melanin. The
bars correspond to 50 lm.
doi:10.1371/journal.pgen.0030195.g001
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remove 29 kDa of the presumably unglycosylated intracellular
part of the protein (Figure 3).
Analysis of White Horses from other Breeds
We sequenced all 21 KIT exons in 16 other white or
partially depigmented horses from other breeds (Arabian,
Camarillo White Horses, Thoroughbred, Miniature Horse,
Shetland Pony). Eight of these 16 horses carried nonsynon-
ymous mutations in the KIT coding sequence. Two related
white Arabians had a nonsense mutation in exon 4
(c.706A.T, Figure 2B), which was predicted to truncate the
protein in the extracellular domain (p.K236X). A third
Arabian horse in the family with minor white spotting did
not have the mutation. The mutation showed perfect
cosegregation with the dominant white phenotype in the
family of the tested Arabians (Figure S1). It was absent from
20 unrelated solid-colored Arabians and also from 110 solid-
colored Franches-Montagnes Horses that were genotyped as
controls (Table S1).
Three Camarillo White Horses were heterozygous for a
missense mutation in exon 12 (c.1805C.T, Figure 2C). This
mutation affects the intracellular tyrosine kinase domain of
the KIT protein and replaces the small side chain of alanine
602 with the much larger side chain of a valine (p.A602V). The
mutation was exclusively found in the white horses from the
family of the tested Camarillo White Horses (Figure S1).
Camarillo White Horses are an open breed and can be mated
to horses from other populations without restrictions.
However, only white offspring of such matings can be
registered as a Camarillo White Horse. Therefore, it was
not possible to analyze solid-colored horses from the same
registry as controls. However, the mutation was absent from
169 solid-colored horses of various breeds (Table S1).
Three related white Thoroughbreds were heterozygous for
a missense mutation in exon 13 (c.1960G.A, Figure 2D). This
mutation also affects the intracellular tyrosine kinase domain
of the KIT protein and leads to a nonconservative exchange
of glycine-654 with arginine (p.G654R). The cosegregation of
the mutation was conﬁrmed in the family of the tested
animals (Figure S1). This mutation was absent from 17 solid-
colored Thoroughbreds and 97 solid-colored Franches-
Montagnes Horses (Table S1).
The presence of the c.1805C.T and c.1960G.A poly-
morphisms was independently conﬁrmed by RFLP analyses.
We did not ﬁnd any mutations affecting the KIT coding
sequence in the remaining eight horses with depigmentation
phenotypes. These horses were ﬁve almost completely white
Thoroughbreds, one Arabian Horse with minor white
spotting, one Miniature Horse with ;50 % depigmented
skin area, and one Shetland Pony with ;75% depigmented
skin area.
Discussion
The data of this study strongly suggest that the c.2151C.G
mutation causes the dominant white phenotype segregating
in the Franches-Montagnes Horses. As the mutation repre-
sents a nonsense mutation, which leads to the truncation of
the functionally important second half of the intracellular
tyrosine kinase domain of the KIT protein, it seems justiﬁed
to assume that this mutation severely affects KIT function.
Furthermore, the perfect association of this mutation with
the dominant white phenotype in cohorts of 20 white and 112
solid-colored Franches-Montagnes Horses corroborates the
causative role of the c.2151C.G mutation. The observed
association would also be compatible with a scenario of a
closely adjacent causative mutation, which is in linkage
disequilibrium with the c.2151C.G mutation. However, we
Table 1. KIT Gene Polymorphisms
Polymorphism
(cDNA)a
Polymorphism
(Genomic DNA)b
Position within
KIT Gene
Protein Breedc Association with
Dominant White (W)
c.87T.G g.91214T.G Exon 1, 59 UTR FM,Tb, Ar white & solid colored
c.706A.T g.131675A.T Exon 4 K236X Ar 3 of 3 white Ar
c.1805C.T g.160429C.T Exon 12 A602V CW 6 of 6 white CW
c.1867þ19C.T g.160510C.T Intron 12 FM, Tb, SP white and solid colored
c.1960G.A g.160670G.A Exon 13 G654R Tb 3 of 8 white Tb
c.2045A.G g.161990A.G Exon 14 H682R FM, Tb, Ar, CW white and solid colored
c.2100G.A g.162045G.A Exon 14 silent FM, Tb, Ar white and solid colored
c.2151C.G g.164267C.G Exon 15 Y717X FM 20 of 20 white FM
c.2244G.A g.164858G.A Exon 16 silent FM, Tb, Ar, CW white and solid colored
c.2472þ11A.G g.166149A.G Intron 17 FM, Tb, Ar white and solid colored
c.2472þ181A.G g.166319A.G Intron 17 FM, Tb, Ar white and solid colored
c.247337A.G g.169415A.G Intron 17 FM, Ar white and solid colored
c.268536A.G g.170099A.G Intron 19 FM, Ar, CW white and solid colored
c.2739C.T g.170189C.T Exon 20 silent FM, Tb, Ar, CW, MH, SP white and solid colored
c.279128C.G g.171356C.G Intron 20 FM, Tb, Ar, CW, MH, SP white and solid colored
c.*136C.T g.171648C.T Exon 21, 39 UTR FM, Ar white and solid colored
c.*252G.A g.171764G.A Exon 21, 39 UTR FM, Ar white and solid colored
c.*285C.T g.171797C.T Exon 21, 39 UTR FM, Ar white and solid colored
aNumbering refers to accession number AF055037.
bNumbering refers to accession number AM420315.
cThis column indicates in which breed(s) the polymorphism was observed.
Ar, Arabian; CW, Camarillo White Horse; FM, Franches-Montagnes; MH, Miniature Horse; SP, Shetland Pony; and Tb, Thoroughbred.
doi:10.1371/journal.pgen.0030195.t001
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regard this as very unlikely, as we can rule out any mutations
in the other exons of the KIT gene. Therefore, it would be
difﬁcult to postulate a different causative mutation with a
more dramatic effect on the KIT protein than the c.2151C.G
mutation, which causes the truncation of more than a quarter
of the protein, including the entire second intracellular
tyrosine kinase domain.
A similar argument holds true for the c.706A.T mutation,
which segregated in a family of white Arabians. This mutation
is predicted to truncate more than three quarters of the
protein, including ligand binding domain, transmembrane
domain, and the entire intracellular part of the KIT protein.
The prediction of the functional impact of the two
missense mutations found in Thoroughbreds and Camarillo
White Horses is not quite as straightforward. However, both
mutations affect the functionally important ﬁrst intracellular
tyrosine kinase domain, and comparable mutations of this
domain have been shown to cause piebaldism in humans and
depigmentation phenotypes in mice (Figure S2).
The c.2151C.G mutation was conﬁrmed on the genomic
and on the cDNA level. Apparently, only about half of the
mutant KIT mRNA is cleared by NMD, although it does
contain a premature stop codon. Investigation of the mutant
protein expression in skin samples of a dominant white (W/þ)
and a solid-colored (þ/þ) horse by western blot showed a
strong band of the expected size in the solid-colored (þ/þ)
horse and weak bands corresponding to the sizes of the wild-
type and the truncated protein in a dominant white (W/þ)
horse. Thus, the western blot indicated that the truncated
protein is indeed expressed. It seems conceivable that a
truncated KIT protein lacking the second half of the
intracellular tyrosine kinase domain forms inactive dimers
with wild-type KIT proteins and acts as a dominant-negative
protein. The observed variation in the coat color phenotypes
of horses with the c.2151C.G mutation (Figure 1A–1C) could
be explained by different efﬁcacies of NMD in different
individuals and in different body regions. If the mutant
transcript is efﬁciently cleared by NMD, then the remaining
wild-type allele could possibly produce enough functional
KIT protein to facilitate pigmentation to some extent.
However, the more that the truncated KIT protein is
expressed, the less likely it is that enough functional dimers
of wild-type KIT proteins can mediate proper KIT signaling.
Our data indicate allelic heterogeneity among dominant
white horses from different breeds. Thus, our study repre-
sents another example where different mutations in a single
gene have been described for a Mendelian trait in domestic
animals similar to the situation in, e.g., brown coat color in
dogs or syndactyly in cattle [19,20]. At this time, it is not
known whether the depigmentation of the other reported
white horses is caused by as-yet undescribed mutations at the
KIT locus or whether mutations in other genes can also cause
this phenotype. The striking phenotype and the autosomal
dominant inheritance facilitate the identiﬁcation of founder
animals. In each of the four investigated families, the white
founder animals born out of solid-colored parents are known:
for the Franches-Montagnes Horses, it is the white mare
Cigale, born in 1957. In the Arabian family, the presumed
founder stallion was born in 1996. The white stallion Sultan,
born in 1912, is the reported founder of the Camarillo White
Horses. The white founder animal of the Thoroughbred
family segregating the c.1960G.A mutation is most likely a
Figure 2. Mutations in the Equine KIT Gene
Direct sequencing of genomic PCR products from solid-colored and
dominant white horses revealed four nonsynonymous polymorphisms
that were exclusively found in white horses. (A) Exon 15, c.2151C.G
mutation in a white Franches-Montagnes Horse.
(B) Exon 4, c.706A.T mutation in a white Arabian.
(C) Exon 12, c.1805C.T mutation in a Camarillo White Horse.
(D) Exon 13, c.1960G.A mutation in a White Thoroughbred.
(E) Electropherograms of exon 15 sequences from a dominant white
Franches-Montagnes Horse derived from genomic DNA and cDNA. The
presence of the polymorphism is clearly visible on the genomic DNA and
on the transcript level. The reduced signal intensity of the mutant G
allele in the cDNA sequence indicates a reduction of the mutant
transcripts compared to the wild-type transcripts of about 50%.
doi:10.1371/journal.pgen.0030195.g002
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stallion born in 1946. In line with the recent origin of these
mutation events, the four proposed candidate causative
mutations of this study segregate only within the four
respective families. In contrast, all of the other 14 KIT
polymorphisms that were discovered during the initial
mutation analysis segregate in at least two distinct horse
populations, indicating that they are much older and spread
into different horse populations by the ongoing admixture,
which is typical for many modern horse breeds.
KIT gene mutations have been described in humans with
piebaldism [13–15], in W mouse mutants [16,17], and in
dominant white pigs [21]. White spotting or white coat color
is a common trait in many breeds of domestic animals, but in
many instances the molecular mechanisms for these depig-
mentation phenotypes are still unknown. In the horse, a
mutation in the EDNRB gene encoding the endothelin
receptor B causes the overo spotting pattern in the
heterozygous state. When this mutation is present in the
homozygous state, completely depigmented foals are born
that usually die within the ﬁrst few days of life, due to
intestinal aganglionosis [22]. The equine KIT gene plays a
central role in equine pigmentation, as at least four distinct
depigmentation phenotypes are known to be associated with
mutations at the equine KIT locus. Of the equine KIT
mutations, so far, only the mutations for sabino-1 and
tobiano have been elucidated at the molecular level. The
mutations for the sabino-1 and tobiano spotting patterns do
not change the KIT coding sequence, but rather reduce the
expression of functional KIT transcripts. Tobiano (TO) acts
strictly autosomal dominant, and TO/TO horses are viable,
fertile, and phenotypically indistinguishable from TO/þ
horses [7]. Sabino-1 (SB1) acts semidominant, and SB1/SB1
horses are viable and almost completely white, whereas SB1/þ
horses show a characteristic sabino spotting pattern [6].
Dominant white (W) produces a variable but rather severe
depigmentation phenotype in heterozygous horses (W/þ). In
the mouse, more than 90 different Kit alleles are known.
Many of these mutations produce some degree of white
spotting in the heterozygous state, which can range from tiny
white belly spots to .99% depigmentation. Many KIT
regulatory mutations exist that produce severe pigmentation
phenotypes in the heterozygous state. However, some of the
murine structural mutations, such as the KitW-42J mutation,
also lead to an almost complete depigmentation in the
heterozygous state. In the mouse, mutations causing a
pronounced dominant depigmentation phenotype typically
also lead to mild anemia and reduced male fertility even in
the heterozygous state [23]. We are not aware of any speciﬁc
health problems in the studied white horses. At least two of
the white Thoroughbreds with the c.1960G.A mutation
successfully competed in horse races, indicating a very good
general ﬁtness. There are very little data on fertility in white
horses; however, one white Franches-Montagnes stallion was
successfully used for artiﬁcial insemination, and all routine
sperm parameters from this stallion were normal. Therefore,
from the limited available data, it appears that heterozygous
KIT mutations may have less detrimental effects in horses on
hematopoiesis and fertility than in mice. In horses, dominant
white was reported to cause embryonic lethality in the
homozygous state [4]. However, this report on the embryonic
lethality was derived from the analysis of offspring phenotype
ratios in a single herd segregating one or more unknown
mutations. As there is now evidence for allelic heterogeneity,
it remains to be proven whether all equine dominant white
mutations cause embryonic lethality in the homozygous state.
While this is certainly likely for the two nonsense mutations
found in Franches-Montagnes Horses and Arabians, it should
not necessarily be assumed for the two reported missense
mutations or for any of the other as-yet unknown W
mutations.
White horses have always fascinated their human owners.
The majority of ‘‘white’’ horses probably carry the greying-
with-age mutation [24], which means that they are born solid
colored and become white at the age of four to six years.
However, there are also a number of historical reports that
explicitly mention white-born horses resembling the pheno-
type of dominant white horses [1,25]. Two thousand years
ago, the Romans already knew of the phenotypic differences
of depigmented horses, which they described as candidus
(white) or glaucus (grey) [26]. The Roman historian Tacitus
described the use of sacred white horses for auguries by
German tribes [27]. The so-called white horse of the Saxons is
depicted on the ﬂags of the German states of Lower Saxony
and North Rhine-Westphalia. It is thus of considerable
historic interest to trace the origins of white horses,
particularly because the nature of their white color can have
different causes, some of which are KIT mutations such as
those described here. We do not know whether the Roman
terms candidus and glaucus actually correspond to our
modern coat color designations of white and grey. Archae-
ogenetics on historic DNA samples may help to identify the
genetic constitution of these horses.
In conclusion, we have identiﬁed the probable causative
mutation for the dominant white phenotype in Franches-
Montagnes Horses. We have also identiﬁed three additional
candidate causative mutations in Arabians, Camarillo White
Horses, and Thoroughbreds. The knowledge of these muta-
tions will allow genetic testing and should help to assign more
precise coat color descriptions for partially or completely
depigmented horses.
Figure 3. Western Blot Analysis of KIT Protein Expression in Skin Samples
A strong band of the expected size of glycosylated wild-type KIT protein
was detected in the protein sample from the solid-colored horse. Protein
extract from the skin of a dominant white horse yielded two very weak
bands. The sizes of the two bands corresponded to wild-type and
truncated KIT protein, respectively. As the skin sample from the
dominant white horse did not contain melanocytes, the weak bands
presumably were due to other KIT-expressing cells that may have been
present in the skin biopsy.
doi:10.1371/journal.pgen.0030195.g003
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Materials and Methods
Animals. All 21 KIT exons were analyzed in 138 horses of six
different breeds. The animals consisted of 118 solid-colored horses
(112 Franches-Montagnes, six Arabian), four white Franches-Mon-
tagnes, and 16 horses registered as maximal sabino (eight Thorough-
breds from three independent families, three related Arabians, three
related Camarillo White Horses, one Miniature Horse, and one
Shetland Pony). These 16 horses had been typed for the absence of
the sabino-1- and tobiano-causing mutations [6,7]. In the Franches-
Montagnes breed, horses with spotting phenotypes (sabino, tobiano,
and overo) may not be registered; therefore, we assumed these
mutations to be absent from the Franches-Montagnes population.
Sixteen additional white Franches-Montagnes Horses were genotyped
for the presence of the c.2151C.G mutation.
Additional solid-colored animals from various breeds (Arabian,
Missouri Fox Trotter, Quarter Horse, Spanish Mustang, Spotted
Draft, Spotted Mountain Horse, and Thoroughbred) were tested for
the absence of the four candidate causative mutations.
DNA and RNA extraction. Genomic DNA was isolated from
peripheral blood or hair roots using standard methods. RNeasy spin
columns were used to isolate total RNA from a solid-colored horse
(skin, small intestine, colon, and testis) and a white horse (skin)
according to the manufacturer’s protocol (Qiagen). Additionally, total
RNA was isolated from white blood cells of the white horse using
TRIzol reagent (Invitrogen) according to the manufacturer’s protocol.
DNA sequencing. The BAC clone CH241-440E11 from the CHORI-
241 library was predicted to contain the equine KIT gene, based on
BAC end sequence comparative mapping [28]. DNA from this clone
was isolated using the Qiagen large construct kit (Qiagen). The
puriﬁed BAC DNA was sheared to approximately 2–5 kb fragments
using a nebulizer, and a shotgun plasmid library was prepared in the
vector pCR4Blunt-TOPO (Invitrogen). Template DNA for sequencing
was prepared using TempliPhi (GE Healthcare) and shotgun plasmid
clones were sequenced to approximately 6-fold coverage using the
BigDye v3.1 kit and an ABI 3730 capillary sequencer (Applied
Biosystems). After sequencing a random collection of plasmid
subclones, the remaining gaps were closed by a primer walking
strategy. Sequence data were assembled with Sequencher 4.6
(GeneCodes). Comparison of the obtained genomic DNA sequence
with a published KIT cDNA sequence (AJ224645) allowed the
annotation of the exons.
PCR and mutation analysis. Primers for the ampliﬁcation of each
of the 21 KIT exons with ﬂanking regions were designed with the
software Primer3 (http://frodo.wi.mit.edu/cgi-bin/primer3/
primer3_www.cgi) after masking repetitive sequences with Repeat-
Masker (A. F. A. Smit and P. Green, http://repeatmasker.genome.
washington.edu/). The sequences of the primers are listed in Table S2.
PCR products were ampliﬁed in 20 ll reactions using AmpliTaq Gold
DNA polymerase (Applied Biosystems) and checked for yield and
purity on agarose gels. Direct sequencing of the PCR products was
performed after shrimp alkaline phosphatase (Roche) and exonuclease
I treatment (New England Biolabs). PCR products were sequenced as
described above using both PCR primers as sequencing primers. In
some instances, additional internal sequencing primers were used.
RFLP analysis. PCR products were subjected to RFLP analyses to
conﬁrm the presence of three nonsynonymous mutations. The
presence of the c.1805C.T mutation was veriﬁed using the enzyme
HaeIII. The c.1960G.A mutation was veriﬁed with DdeI, and the
c.2151C.G mutation with BccI. The restriction fragments were
separated on standard agarose gels and genotypes were determined
from the resulting band patterns.
RT-PCR. Aliquots of 1 lg total RNA were reverse transcribed into
cDNA using 20 pmol (T)24V primer and Omniscript reverse
transcriptase (Qiagen). Two microliters of the cDNA were used as a
template in PCR. PCRs were performed as described above.
Immunohistochemistry. Epidermis from a solid-colored and a
white horse was ﬁxed in formalin-buffered saline and embedded in
parafﬁn. Tissue sections (5 mm) were dewaxed in xylene for 7 min,
dehydrated in alcohol, and then rinsed with PBS. For exposure and
detection of KIT protein, antigen retrieval was performed in Tris-
EDTA (pH 9) in the microwave for 15 min. Nonspeciﬁc binding was
blocked by incubating the sections in 5% normal donkey serum
(Dako) in Tris-buffered saline for 30 min. Negative control studies
were performed without primary antibody. We used a goat antibody
directed against the extracellular domain of mouse c-kit (R&D
Systems) at a concentration of 2 lg/ml. Binding was detected using an
alkaline phosphatase donkey-anti-goat IgG (Jackson Immuno Re-
search) at a dilution of 1:200 for 60 min. Sections were washed in PBS
and subsequently visualized using BCIP/NBT (Dako).
Western blot. For skin protein extraction, minced skin samples
were incubated overnight at 4 8C with RIPA extraction buffer (Pierce)
containing 25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1%
sodium deoxycholate, and 0.1% SDS, complemented with Halt
protease inhibitor cocktail (Pierce) and 8 M urea. After centrifuga-
tion at 15,000 xg for 10 min at 4 8C, the supernatants were collected
and protein concentration was determined using a Bradford assay
(Bio-Rad). Protein extracts (20 lg) were boiled for 5 min in reducing
sample buffer and separated by 12% SDS-PAGE. Proteins were
electrically transferred to a polyvinylidene diﬂuoride (PVDF)
membrane. After blocking with 5% skim milk, the membrane was
incubated with a chicken IgY afﬁnity-puriﬁed polyclonal antibody
directed against the N-terminus of human KIT (GenWay) diluted
1:1,000. Detection was performed using an alkaline phosphatase–
conjugated anti-IgY secondary antibody (Jackson Immuno Research)
diluted 1:5,000 and BCIP/NBT (Dako).
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